Gastrointestinal Cancer
News
Neoadjuvant chemoradiotherapy fails to boost survival
Key clinical point: Don’t postpone surgery for esophageal cancer to perform chemoradiotherapy.Major finding: Median overall survival was 31.8...
Conference Coverage
Vascular reconstruction may have a role in pancreatic adenocarcinoma resection
Key clinical point: Performing a Whipple on borderline T3 lesions with vascular invasion may allow for an increased amount of surgical resections....
News
Genetic marker for better colon cancer prognosis halved among African Americans
Key clinical point: Racial disparity in colon cancer mortality may be due in part to biological differences in tumor type.Major finding: The...
Conference Coverage
Refining prognosis in small intestinal neuroendocrine tumors
Key clinical point: The extent of lymph node involvement provides important independent prognostic information in patients with early-stage, T1,...
News
Vaccine-chemo combination boosts immunotherapy in pancreatic cancer
Key clinical point: A therapeutic vaccine combined with low-dose chemotherapy converted pancreatic ductal adenocarcinomas into immunogenic cancers...
Conference Coverage
Screen for Barrett’s in all with central obesity?
Key clinical point: The current recommended strategy of screening for Barrett’s esophagus on the basis of symptoms of gastroesophageal reflux is...
News
Targeting inflammation improved survival for some patients with advanced pancreatic cancer
Major finding: Median overall survival of patients with metastatic pancreatic cancer with CRP levels above 13 mg/L treated with ruxolitinib and...
News
Time to look beyond wild-type KRAS in metastatic CRC?
Major finding: Among 63 patients with metastatic colorectal cancer with wild-type KRAS exon 2 but new RAS mutations in other exons, there was no...
News
Maintenance improves PFS in patients with metastatic colorectal cancer
Key clinical point: Patients with metastatic colorectal cancer who have at least stable disease after induction chemotherapy may benefit from...
Conference Coverage
Tests pinpoint primary sources of neuroendocrine bowel, pancreatic metastases
Key clinical point: Gene expression can be used to identify the primary source of neuroendocrine small bowel and pancreatic metastases.Major...
News
Long-term follow-up shows 22% survival rate for advanced GIST
Major finding: Ten-year overall survival for patients with metastatic or unresectable gastrointestinal tumors (GIST) treated with imatinib was 22...